commonly used oral anticoagulants (OAC) are the synthetic coumarin derivatives warfarin, acenocoumarol and phenprocoumon, which are indicated in patients with atrial fibrillation and prosthetic cardiac valves [2]. Even though new oral anticoagulants have recently been introduced such as Dabigatran (FIIa inhibitor), and Apixaban (FXa inhibitor) which are being implemented as preventive drugs after knee and hip replacement surgery to avoid post operative complications [3], coumarin is still associated with an increased incidence of bleeding, which is found to be a recognized complication affecting approxi-mately 1 % of the patients treated with OAC and about half of these patients die from bleeding complications annually [5]. Current treatmen...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban, apixaban and edoxaban form a new...
Contains fulltext : 98000.pdf (publisher's version ) (Open Access)Bleeding is the ...
Abstract Background and objectives The number of patients treated with oral anticoagulation (OAC) is...
BACKGROUND:Anticoagulation with vitamin K antagonists such as warfarin has historically been used fo...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Thrombosis is an aggravation that contributes to significant morbidity and mortality rates, being a ...
Ease of dosing and simplicity of monitoring make new oral anticoagulants an attractive therapy in a ...
New oral anticoagulants like the direct thrombin inhibitor, dabigatran (Pradaxa®), and factor Xa-inh...
Thromboembolic diseases are one of the leading causes of morbidity and mortality worldwide. For a lo...
Thromboembolic diseases are one of the leading causes of morbidity and mortality worldwide. For a lo...
Managing patients in the perioperative setting receiving novel oral anticoagulation agents for throm...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban, apixaban and edoxaban form a new...
Contains fulltext : 98000.pdf (publisher's version ) (Open Access)Bleeding is the ...
Abstract Background and objectives The number of patients treated with oral anticoagulation (OAC) is...
BACKGROUND:Anticoagulation with vitamin K antagonists such as warfarin has historically been used fo...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
Thrombosis is an aggravation that contributes to significant morbidity and mortality rates, being a ...
Ease of dosing and simplicity of monitoring make new oral anticoagulants an attractive therapy in a ...
New oral anticoagulants like the direct thrombin inhibitor, dabigatran (Pradaxa®), and factor Xa-inh...
Thromboembolic diseases are one of the leading causes of morbidity and mortality worldwide. For a lo...
Thromboembolic diseases are one of the leading causes of morbidity and mortality worldwide. For a lo...
Managing patients in the perioperative setting receiving novel oral anticoagulation agents for throm...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Oral anticoagulants (OA) are effective drugs for treating and preventing the formation of blood clot...
Thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban, apixaban and edoxaban form a new...
Contains fulltext : 98000.pdf (publisher's version ) (Open Access)Bleeding is the ...